Patents Assigned to XITIAN ZHANG
  • Single domain antibody and derivative proteins thereof against CTLA4
    Patent number: 11912768
    Abstract: The present invention relates to the field of medical biology, and discloses a single domain antibody and derivative proteins thereof against CTLA4. In particular, the present invention discloses a CTLA4 binding protein and the use thereof, especially the use for treating and/or preventing CTLA4 relevant diseases such as tumor.
    Type: Grant
    Filed: July 7, 2021
    Date of Patent: February 27, 2024
    Assignees: SUZHOU ALPHAMAB CO., LTD., XITIAN ZHANG, XIN ZHANG
    Inventors: Ting Xu, Xiaoxiao Wang, Jie Li, Haiyan Wu, Li Gao, Qian Chu, Yu Bai
  • Single domain antibody and derivative proteins thereof against CTLA4
    Patent number: 11091549
    Abstract: The present invention relates to the field of medical biology, and discloses a single domain antibody and derivative proteins thereof against CTLA4. In particular, the present invention discloses a CTLA4 binding protein and the use thereof, especially the use for treating and/or preventing CTLA4 relevant diseases such as tumor.
    Type: Grant
    Filed: May 19, 2017
    Date of Patent: August 17, 2021
    Assignees: SUZHOU ALPHAMAB CO., LTD., XITIAN ZHANG, XIN ZHANG
    Inventors: Ting Xu, Xiaoxiao Wang, Jie Li, Haiyan Wu, Li Gao, Qian Chu, Yu Bai